Literature DB >> 7060546

Methods and approaches for assessing immunotoxicity: an overview.

J H Dean, M I Luster, G A Boorman.   

Abstract

The goals of the National Toxicology Program as they relate to immunological evaluation in toxicity assessment are discussed. The advantages of immune function assays for defining cellular injury as subtoxic levels following exposure to general or immunocyte specific chemical toxicants are proposed. A comprehensive screening panel of immune function and host resistance assays is presented in the context of an NIEHS approach for immunotoxicity assessment and methods selection. A second panel for defining the mechanism underlying immunological injury was also described. Studies utilizing these methods and approaches are described in companion papers by our group.

Entities:  

Mesh:

Year:  1982        PMID: 7060546      PMCID: PMC1568892          DOI: 10.1289/ehp.824327

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  1 in total

1.  Long-term effects of neonatal estrogen treatment on mitogen responsiveness of mouse spleen lymphocytes.

Authors:  T Kalland; O Strand; J G Forsberg
Journal:  J Natl Cancer Inst       Date:  1979-08       Impact factor: 13.506

  1 in total
  3 in total

1.  Immune parameters of plaice, Pleuronectes platessa, L. along a sewage sludge gradient in the Firth of Clyde, Scotland.

Authors:  C J Secombes; A White; T C Fletcher; R Stagg; D F Houlihan
Journal:  Ecotoxicology       Date:  1995-10       Impact factor: 2.823

Review 2.  Developmental Immunotoxicity, Perinatal Programming, and Noncommunicable Diseases: Focus on Human Studies.

Authors:  Rodney R Dietert
Journal:  Adv Med       Date:  2014-01-23

Review 3.  From Suppressor T cells to Regulatory T cells: How the Journey That Began with the Discovery of the Toxic Effects of TCDD Led to Better Understanding of the Role of AhR in Immunoregulation.

Authors:  Narendra Prasad Singh; Mitzi Nagarkatti; Prakash Nagarkatti
Journal:  Int J Mol Sci       Date:  2020-10-22       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.